Camcevi Etm Injection, Emulsion
NDC Package 72851-100-01

11-digit billing NDC: 72851010001
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Camcevi Etm (leuprolide) injection is cAMCEVI ETM is indicated for the treatment of adult patients with advanced prostate cancer. This formulation utilizes a injection, emulsion delivery system. Marketed by Foresee Pharmaceuticals Co., Ltd., this product is identified by NDC 72851-100 and is authorized under FDA application NDA219745.

Identification & Billing

NDC Package Code
72851-100-01
Package Description
1 SYRINGE in 1 CARTON / .3 g in 1 SYRINGE
Product Code
72851-100
11-Digit Billing Format
72851010001

Clinical Specifications

Proprietary Name
Camcevi Etm
Non-Proprietary Name
Leuprolide
Substance Name
Leuprolide Mesylate
Dosage Form
Injection, Emulsion - An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.
Administration Route
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
LEUPROLIDE MESYLATE 21 mg/.3g
Pharmacologic Class
Usage Information
CAMCEVI ETM is indicated for the treatment of adult patients with advanced prostate cancer.

Regulatory & Marketing

Labeler Name
Foresee Pharmaceuticals Co., Ltd.
Product Type
Human Prescription Drug
FDA Application #
NDA219745
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-31-2026
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72851-100-01 identifies a specific commercial package of 1 syringe in 1 carton / .3 g in 1 syringe of Camcevi Etm, a human prescription drug labeled by Foresee Pharmaceuticals Co., Ltd.. This injection, emulsion is formulated for subcutaneous use and contains leuprolide mesylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Foresee Pharmaceuticals Co., Ltd. on October 31, 2026. The current certification is valid through December 31, 2026.

How is this Foresee Pharmaceuticals Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72851010001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72851-100-01
11-Digit CMS (5-4-2)
72851-0100-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.